Gastroenterologist & Hepatologist Auckland City Hospital Auckland

Size: px
Start display at page:

Download "Gastroenterologist & Hepatologist Auckland City Hospital Auckland"

Transcription

1 Dr David Rowbotham Gastroenterologist & Hepatologist Auckland City Hospital Auckland 14:00-14:55 WS #138: IBD in Primary Care - Practical Management Tips 15:05-16:00 WS #150: IBD in Primary Care - Practical Management Tips (Repeated)

2 IBD in Primary Care Practical Management Tips Dr David Rowbotham Consultant Gastroenterologist Dept of Gastroenterology & Hepatology Auckland City Hospital

3 Disclaimer This workshop presentation is supported by Emerge Health. The views and opinions expressed in the following presentation are those of the presenter and do not necessarily reflect those of Emerge Health Ltd. Emerge Health Ltd does not endorse the use of unregistered products or products outside of their registered indications. Please refer to the Product Information or Data Sheet for licensed instructions.

4 Disclosures Advisory Board Abbvie; Janssen; Baxter; Pharmaco; Hospira Speaker fees Abbvie; Janssen; Baxter; Pharmaco; biocsl; Given imaging; Emerge Health

5

6 Outline Aetiology Calprotectin Novel Rx s Stopping treatment Clinical trials (at ADHB) Management tips Clinical MCQs

7 Inflammatory Bowel Disease Diagnosed What s out there

8 Specialist GP

9 GP

10 Understanding IBD behaviours Specialist

11 Crohn s disease behaviour Cosnes, Inflammatory Bowel Diseases 8:

12 Crohn s disease digestive damage Lémann score Pariente Inflammatory Bowel Diseases 17: ,

13 Clinical course of UC Population-based study (the IBSEN study). 454 pts with UC followed over 5 yrs 2006 Inflammatory Bowel Diseases;12:

14 Cumulative colectomy rate in UC Biologic era Population-based study (the IBSEN study)

15 Aetiology? Genetic polymorphisms (susceptibility) Specific environmental factors M. paratuberculosis Oratane (Isotretinoin) Generic immunogenic factor(s) in genetically susceptible individuals

16 Faecal Calprotectin

17 Faecal Calprotectin Auckland labs normal range : 0 50 mcg/g >200 mcg/g sensitivity 70%, specificity 92% PPV 94% NPV 61% in predicting intestinal inflammation

18 Novel therapies? Crohn s Trichuris suis (pig whipworm) Low dose naltrexone (4.5 mg / day) IBD (colitis) FMT (faecal biotherapy / poo transplant) UC (proctitis / distal colitis) Appendicectomy

19 Stopping treatment? 5-ASA Why? Very well tolerated No cumulative side effects (dose or time)

20 Stopping treatment? Immunomodulators

21 Azathioprine withdrawal? Azathioprine (n=40) Placebo (n=43) 0.2 p = Treton X et al. Clin Gastroenterol Hepatol 2009;7:80 85 Time (years)

22 Remission and <10 mg prednisone (%) Azathioprine retreatment? Re-treatment with Azathioprine associated with good response Patients at risk Patients (2 nd course) Controls (1 st course) p = Months Nachury M, et al. Gastroenterol 2003;124(Suppl 1): A-522 (abstr T1381)

23 Stopping treatment? Immunomodulators Why? Significant side effects tend to be immediate If well tolerated, usually doesn t change Skin (BCC / SCC) forever Lymphoma reduction back to baseline

24 Clinical Trials (current/imminent) Selection / Diversity (Filgotinib) Gilead JAK13 kinase inhibitor Moderate - severe Crohn s (phase 3) or UC (phase 2/3) Oral bd Galaxi (Goselkumab) Janssen IL-23 mab Moderate - severe Crohn s IV then SC 8 or 12 weekly

25 Specialists view of colonoscopy

26 Patients view of colonoscopy

27 Tips for GPs Management of IBD flares in the community

28 Tips First presentation or flare Exclude infection Pathogens Parasites CMV Clostridium difficile

29 Tips First treatment 5-ASA (mesalazine) Asacol 400 / 800 mg tabs; 500 mg supp Pentasa 500 mg tab, 1 g sachet, 1 g supp, 1 g enema Asamax 500 mg tab

30 Tips First treatment 5-ASA 5-ASA oral treatment dosage Asacol 4.8 g daily Pentasa 4 g daily Oral and/or topical Doesn t have to be same brand No dose-dependent side effects

31 Tips Escalation 5-ASA 5-ASA dose at least 4 g daily for flares I regularly use >8 g daily 5-ASA route(s) oral and/or topical (can mix brands) No dose dependent side effects

32 Tips De-escalation 5-ASA When do I reduce 5-ASA dose? Do you need to? Clinical remission No dose-dependent side effects 5-ASA oral maintenance dosage Asacol 2.4 g daily Pentasa 2 g daily Oral and/or topical

33 Tips Once diagnosis established Probiotics acidophilus lactobacillus bifidobacteria Diet & Lifestyle triggers? irritants?

34 Tips Natural remedies Probiotics Supplements Aloe vera juice Spirulina Evening primrose oil Beware Womens Magazines!

35 Should I follow a specific diet? Low residue Wheat / gluten-free Lactose-free Anything IBD / IBS

36 Should I follow a specific diet? SCS (Specific Carbohydrate Diet): limits complex carbohydrates, eliminates refined sugar & lactose GAPS (Gut And Psychology Syndrome diet) IBD-AID (IBD Anti-Inflammatory Diet) Paleo diet All similar, exclude most grains (Paleo excludes dairy too) GAPS & IBD-AID small study success; nothing for Paleo Paleo + probiotics (H 2 S vs. butyrate)

37 Tips Corticosteroids?topical in conjunction with 5-ASA Oral steroids dose duration

38 Tips Moderate to severe colitis Prednisone 40 mg/day; reduce 5 mg weekly <15 mg/day ineffective Mild ileo-caecal Crohn s Budesonide 9 mg/day Duration Moderate ileo-caecal Crohn s Budesonide 9 mg/day or Prednisone 40 mg/day EEN no benefit

39 Tips Treatment escalation Disease modifying drugs -?dose Azathioprine mg/kg/day 6-MP 50 mg/day MTX 10 mg bd once weekly

40 Take home messages Exclude infection Suppositories Rx the rectum Enemas Rx the left colon Topical 5-ASAs more effective than topical steroids Think 5-ASA first and last Steroids (last) resort (dose/duration) If worried... call (me)!

41 Do I get bonus points if I act like I care?

42 So how do you become a good doctor? Sir William Osler ( )

43 So how do you become a good doctor? One finger in the throat and one in the rectum makes a good diagnostician Sir William Osler ( )

44 A successful doctor needs three things Samuel Johnson ( )

45 A successful doctor needs three things A top hat to give him authority, Samuel Johnson ( )

46 A successful doctor needs three things A top hat to give him authority, a paunch to give him dignity, Samuel Johnson ( )

47 A successful doctor needs three things A top hat to give him authority, a paunch to give him dignity, and piles to give him an anxious expression. Samuel Johnson ( )

48 Case 1 18 year old female presents with rectal bleeding and mucus, with feelings of incomplete evacuation. Rigid sigmoidoscopy reveals active proctitis with normal mucosa above the rectum. The best initial management is... A. Oral steroids B. Azathioprine C. 5-ASA enema D. 5-ASA suppository E. Rectal swab

49 Case 2 18 year old male presents with rectal bleeding and mucus, with feelings of incomplete evacuation. Rigid sigmoidoscopy reveals active proctitis with normal mucosa above the rectum. The best initial management is... A. Oral steroids B. Azathioprine C. 5-ASA enema D. 5-ASA suppository E. Rectal swab

50 Case 3 65 year old man with Crohn s pancolitis. Stable for years on Pentasa 500mg bd, but now presents to your surgery with gradual deterioration in symptoms with diarrhoea, blood and mucus. Do you... A. Add in regular 5-ASA enemas B. Increase dose of oral 5-ASA C. Add in Azathioprine D. Commence course of oral steroids E. Give course of antibiotics

51 Case 4 30 year old woman with UC (left sided). Diagnosed 2 years ago. Difficult to settle colitis initially, but now stable on 5-ASA and Azathioprine. She arrives at your surgery and reveals she is 7 weeks pregnant. Do you... A. Stop the 5-ASA B. Stop the Azathioprine C. Stop both D. Recommend termination E. Commence folic acid / iodine

52 Case 5 Regular intake of probiotics have been shown to... A. Reduce the number of flare-ups of IBD B. Reduce IBS symptoms (eg: bloating) C. Reduce risk of Clostridium difficile diarrhoea D. All of the above E. None of the above

53 Case 6 Azathioprine / 6-MP are... A. Safe in pregnancy but not breastfeeding B. Safe in breastfeeding but not pregnancy C. Safe in both D. Unsafe in both E. Known teratogens

54 Case 7 MTX is... A. Safe in pregnancy but not breastfeeding B. Safe in breastfeeding but not pregnancy C. Safe in both D. Unsafe in both E. Known teratogens

55 Case 8 With regard to probiotics, true or false... A. All yoghurts contain them B. Capsules are cheap C. Capsules are better than yoghurts D. VSL #3 is the best probiotic strain E. Find a strain that suits you and stick with it F. None of the above

56 Q & A Your turn!

Dr David Rowbotham. The Leeds Teaching Hospitals NHS Trust NHS

Dr David Rowbotham. The Leeds Teaching Hospitals NHS Trust NHS Dr David Rowbotham The Leeds Teaching Hospitals NHS Trust NHS Useful Titbits from the World of Gastroenterology David Rowbotham Clinical Director & Consultant Gastroenterologist Dept of Gastroenterology

More information

IBD Case Studies. David Rowbotham. Clinical Director & Consultant Gastroenterologist Dept of Gastroenterology & Hepatology Auckland City Hospital

IBD Case Studies. David Rowbotham. Clinical Director & Consultant Gastroenterologist Dept of Gastroenterology & Hepatology Auckland City Hospital IBD Case Studies David Rowbotham Clinical Director & Consultant Gastroenterologist Dept of Gastroenterology & Hepatology Auckland City Hospital Dr David Rowbotham The Leeds Teaching Hospitals NHS Trust

More information

IBD :- a new era of diagnostics and therapy Dr Martyn Dibb Consultant Luminal Gastroenterologist Royal Liverpool University Hospital

IBD :- a new era of diagnostics and therapy Dr Martyn Dibb Consultant Luminal Gastroenterologist Royal Liverpool University Hospital IBD :- a new era of diagnostics and therapy Dr Martyn Dibb Consultant Luminal Gastroenterologist Royal Liverpool University Hospital Aims To understand the aetiology of IBD To understand the impact that

More information

CCFA. Crohns Disease vs UC: What is the best treatment for me? November

CCFA. Crohns Disease vs UC: What is the best treatment for me? November CCFA Crohns Disease vs UC: What is the best treatment for me? November 8 2009 Ellen J. Scherl,, MD, FACP,AGAF Roberts Inflammatory Bowel Disease Center Weill Medical College Cornell University New York

More information

Efficacy and Safety of Treatment for Pediatric IBD

Efficacy and Safety of Treatment for Pediatric IBD Efficacy and Safety of Treatment for Pediatric IBD Andrew B. Grossman MD Co-Director, Center for Pediatric Inflammatory Bowel Disease Assistant Professor of Clinical Pediatrics Division of Gastroenterology,

More information

New treatment options in UC. Rob Bryant IBD Consultant Royal Adelaide Hospital

New treatment options in UC. Rob Bryant IBD Consultant Royal Adelaide Hospital New treatment options in UC Rob Bryant IBD Consultant Royal Adelaide Hospital Talk Outline 1. Raising expectations 2. Optimising UC therapy 3. Clinical trials 4. What s new on the PBS? 5. Questions 1.

More information

Efficacy and Safety of Treatment for Pediatric IBD

Efficacy and Safety of Treatment for Pediatric IBD Efficacy and Safety of Treatment for Pediatric IBD Andrew B. Grossman MD Co-Director, Center for Pediatric Inflammatory Bowel Disease Associate Professor of Clinical Pediatrics Division of Gastroenterology,

More information

Primary & Secondary Care Inflammatory Bowel Disease Pathway February 2018

Primary & Secondary Care Inflammatory Bowel Disease Pathway February 2018 South East London Area Prescribing Committee: Primary & Secondary Care Inflammatory Bowel Disease Pathway February 2018 Developed by: South East London IBD Pathway Development Group Approved: February

More information

Doncaster & Bassetlaw Medicines Formulary

Doncaster & Bassetlaw Medicines Formulary Doncaster & Bassetlaw Medicines Formulary Section 1.5 Chronic Bowel Disorders (including IBD) Aminosalicylates: Mesalazine 400mg and 800mg MR Tablets (Octasa) Mesalazine 1.2g MR Tablets (Mezavant XL) Mesalazine

More information

To help protect your privacy, PowerPoint prevented this external picture from being automatically downloaded. To download and display this picture,

To help protect your privacy, PowerPoint prevented this external picture from being automatically downloaded. To download and display this picture, To help protect your privacy, PowerPoint prevented this external picture from being automatically downloaded. To download and display this picture, click Options in the Message Bar, and then click Enable

More information

Dr David Epstein Vincent Pallotti Hospital and University of Cape Town

Dr David Epstein Vincent Pallotti Hospital and University of Cape Town Inflammatory Bowel Disease Management in South Africa in 2016 Pharmaceutical Care Management Association Dr David Epstein Vincent Pallotti Hospital and University of Cape Town Inflammatory Bowel Disease

More information

PEDIATRIC INFLAMMATORY BOWEL DISEASE

PEDIATRIC INFLAMMATORY BOWEL DISEASE PEDIATRIC INFLAMMATORY BOWEL DISEASE Alexis Rodriguez, MD Pediatric Gastroenterology Advocate Children s Hospital Disclosers Abbott Nutrition - Speaker Inflammatory Bowel Disease Chronic inflammatory disease

More information

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 20 October 2010

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 20 October 2010 The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 20 October 2010 MEZAVANT LP 1200 mg, prolonged-release gastro-resistant tablets B/60 (CIP code: 378 689-2) Applicant

More information

Understanding Inflammatory Bowel Diseases (IBD):

Understanding Inflammatory Bowel Diseases (IBD): Understanding Inflammatory Bowel Diseases (IBD): What Every Patient Needs to Know William H Holderman, MD Digestive Health Specialists Tacoma, WA Today s Objectives Define IBD, its potential causes and

More information

Definitions. Clinical remission: Resolution of symptoms (stool frequency 3/day, no bleeding and no urgency)

Definitions. Clinical remission: Resolution of symptoms (stool frequency 3/day, no bleeding and no urgency) CROHN S DISEASE Definitions Clinical remission: Resolution of symptoms (stool frequency 3/day, no bleeding and no urgency) Recurrence: The reappearance of lesions after surgical resection Endoscopic remission:

More information

Current management options and recent advances in IBD

Current management options and recent advances in IBD n DRUG REVIEW Current management options and recent advances in IBD Ben Warner BSc, MRCP and Peter Irving MA, MD, FRCP SPL The advent of biological therapies has revolutionised the management of inflammatory

More information

Top 10 Things you need to know about IBD. Suresh Pola, MD Kaiser San Diego

Top 10 Things you need to know about IBD. Suresh Pola, MD Kaiser San Diego Top 10 Things you need to know about IBD Suresh Pola, MD Kaiser San Diego Top 10 Things to Know: IBD What you can eat How to treat the pain Not all diarrhea is a flare Ways to reduce your risk of getting

More information

Inflammatory or Irritable? (the bowel, not the speaker)

Inflammatory or Irritable? (the bowel, not the speaker) South GP CME Edgar Centre, Dunedin August 2014 Inflammatory or Irritable? (the bowel, not the speaker) Dr Jason Hill MBChB FRACP FRCP Edin Department of Gastroenterology, Southern DHB Dunedin School Of

More information

Dietary Options for Inflammatory Bowel Disease

Dietary Options for Inflammatory Bowel Disease Dietary Options for Inflammatory Bowel Disease Michael J. Rosen, MD, MSCI Schubert-Martin Inflammatory Bowel Disease Center Learning objectives Worldwide rise in the incidence of IBD The relationship between

More information

Irritable bowel syndrome in adults

Irritable bowel syndrome in adults Irritable bowel syndrome in adults NICE provided the content for this booklet which is independent of any company or product advertised Welcome In February 2008, NICE published a clinical guideline on

More information

Predicting the natural history of IBD. Séverine Vermeire, MD, PhD Department of Gastroenterology University Hospital Leuven Belgium

Predicting the natural history of IBD. Séverine Vermeire, MD, PhD Department of Gastroenterology University Hospital Leuven Belgium Predicting the natural history of IBD Séverine Vermeire, MD, PhD Department of Gastroenterology University Hospital Leuven Belgium Patient 1 Patient 2 Age 22 Frequent cramps and diarrhea for 6 months Weight

More information

The York Faecal Calprotectin Care Pathway for use in primary care. James Turvill

The York Faecal Calprotectin Care Pathway for use in primary care. James Turvill The York Faecal Calprotectin Care Pathway for use in primary care James Turvill NICE guidance: dg11 Faecal calprotectin (FC) testing as an option in adults with recent onset of lower gastrointestinal symptoms

More information

Treatment Options. Suresh Pola, MD Kaiser San Diego

Treatment Options. Suresh Pola, MD Kaiser San Diego Treatment Options Suresh Pola, MD Kaiser San Diego Overview of Treatments! Medications! Diet! Complementary and Alternative Medicines! How to treat Pain Treatment Goals and Target! Goals of Treatment should

More information

Personalized Medicine in IBD

Personalized Medicine in IBD Personalized Medicine in IBD Anita Afzali MD, MPH Assistant Professor of Medicine Director, Inflammatory Bowel Diseases Program University of Washington Harborview Medical Center CCFA April 2 nd, 2016

More information

Complementary & Alternative Therapies in IBD

Complementary & Alternative Therapies in IBD Complementary & Alternative Therapies in IBD Laurie Rosales, APRN-CNP OSU Wexner Medical Center Division of Gastroenterology, Hepatology and Nutrition Complementary & Alternative Probiotics Cannabis Fish

More information

Medical Therapy for Pediatric IBD: Efficacy and Safety

Medical Therapy for Pediatric IBD: Efficacy and Safety Medical Therapy for Pediatric IBD: Efficacy and Safety Betsy Maxwell, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition Pediatric IBD: Defining Remission

More information

Treatment of Inflammatory Bowel Disease. Michael Weiss MD, FACG

Treatment of Inflammatory Bowel Disease. Michael Weiss MD, FACG Treatment of Inflammatory Bowel Disease Michael Weiss MD, FACG What is IBD? IBD is an immune-mediated chronic intestinal disorder, characterized by chronic or relapsing inflammation within the GI tract.

More information

Disclosures. What Do I Do When Anti-TNF Therapy Is Not Working Anymore? Fadi Hamid, M.D. Saint Luke s GI Specialists

Disclosures. What Do I Do When Anti-TNF Therapy Is Not Working Anymore? Fadi Hamid, M.D. Saint Luke s GI Specialists What Do I Do When Anti-TNF Therapy Is Not Working Anymore? Fadi Hamid, M.D. Saint Luke s GI Specialists Disclosures No financial relationships to disclose. 1 Learning Objectives Case 24M with ileocolonic

More information

Position of Biologics in IBD Circa 2006: Top Down vs. Step Up Therapy

Position of Biologics in IBD Circa 2006: Top Down vs. Step Up Therapy Position of Biologics in IBD Circa 2006: Top Down vs. Step Up Therapy Stephen B. Hanauer, MD University of Chicago Potential Conflicts: Centocor/Schering, Abbott, UCB, Elan, Berlex, PDL Goals of Treatment

More information

Mucosal Healing in Crohn s Disease. Geert D Haens MD, PhD University Hospital Gasthuisberg University of Leuven Leuven, Belgium

Mucosal Healing in Crohn s Disease. Geert D Haens MD, PhD University Hospital Gasthuisberg University of Leuven Leuven, Belgium Mucosal Healing in Crohn s Disease Geert D Haens MD, PhD University Hospital Gasthuisberg University of Leuven Leuven, Belgium Mucosal Lesions in CD: General Features CD can affect the entire GI tract

More information

Dietary advice for people with Inflammatory Bowel Disease

Dietary advice for people with Inflammatory Bowel Disease Dietary advice for people with Inflammatory Bowel Disease Crohn s disease and Ulcerative colitis Information for patients Name Your Dietitian Dietitian contact number: 0118 322 7116 What is Inflammatory

More information

ULCERATIVE COLITIS. Sean Lynch, MD and Richard Bloomfeld, MD Wake Forest University School of Medicine Winston-Salem, NC

ULCERATIVE COLITIS. Sean Lynch, MD and Richard Bloomfeld, MD Wake Forest University School of Medicine Winston-Salem, NC ULCERATIVE COLITIS Sean Lynch, MD and Richard Bloomfeld, MD Wake Forest University School of Medicine Winston-Salem, NC What is Ulcerative Colitis? Ulcerative colitis (UC) is a disease marked by inflammation

More information

IBD Understanding Your Medications. Thomas V. Aguirre, MD Santa Barbara GI Consultants

IBD Understanding Your Medications. Thomas V. Aguirre, MD Santa Barbara GI Consultants IBD Understanding Your Medications Thomas V. Aguirre, MD Santa Barbara GI Consultants IBD Understanding Your Medications (& Your Doctor) Thomas V. Aguirre, MD Santa Barbara GI Consultants Disclosure I

More information

Treatment Goals. Current Therapeutic Pyramids Crohn s Disease Ulcerative Colitis 11/14/10

Treatment Goals. Current Therapeutic Pyramids Crohn s Disease Ulcerative Colitis 11/14/10 Current Management of IBD: From Conventional Agents to Biologics Stephen B. Hanauer, M.D. University of Chicago Treatment Goals Induce and maintain response/ remission Prevent complications Improve quality

More information

Standard of care Inflammatory Bowel Disease (IBD)

Standard of care Inflammatory Bowel Disease (IBD) Standard of care Inflammatory Bowel Disease (IBD) Inflammatory bowel disease (IBD) Tens of thousands of Australians live with the debilitating symptoms of Crohn s disease or ulcerative colitis the two

More information

Endpoints for Stopping Treatment in UC

Endpoints for Stopping Treatment in UC Endpoints for Stopping Treatment in UC Jana G. Hashash, MD Assistant Professor of Medicine Inflammatory Bowel Disease Center Division of Gastroenterology, Hepatology, and Nutrition University of Pittsburgh

More information

My Child Has Inflammatory Bowel Disease : Why? What now? What s next?

My Child Has Inflammatory Bowel Disease : Why? What now? What s next? My Child Has Inflammatory Bowel Disease : Why? What now? What s next? George M. Zacur, M.D., M.S. Clinical Assistant Professor Department of Pediatrics and Communicable Diseases Division of Gastroenterology

More information

Implementation of disease and safety predictors during disease management in UC

Implementation of disease and safety predictors during disease management in UC Implementation of disease and safety predictors during disease management in UC DR ARIELLA SHITRIT DIGESTIVE DISEASES INSTITUTE SHAARE ZEDEK MEDICAL CENTER JERUSALEM Case presentation A 52 year old male

More information

Update on IBD. Dr Richard POLLOK Consultant Gastroenterologist and Honorary Senior Lecturer. Queen Mary s Hospital. St George s Hospital

Update on IBD. Dr Richard POLLOK Consultant Gastroenterologist and Honorary Senior Lecturer. Queen Mary s Hospital. St George s Hospital Update on IBD Dr Richard POLLOK Consultant Gastroenterologist and Honorary Senior Lecturer Queen Mary s Hospital St George s Hospital Parkside Hospital Miss LF, aged 24 Recent diagnosis of distal colitis

More information

Moderately to severely active ulcerative colitis

Moderately to severely active ulcerative colitis Adalimumab in the Treatment of Moderate-to-Severe Ulcerative Colitis: ULTRA 2 Trial Results Sandborn WJ, van Assche G, Reinisch W, et al. Adalimumab induces and maintains clinical remission in patients

More information

Preventing post-operative recurrence

Preventing post-operative recurrence Oxford Inflammatory Bowel Disease MasterClass Preventing post-operative recurrence Dr Oliver Brain Oxford Disclosures Presented at IEE, Oxford 2013 AbbVie sponsored meeting Talk Outline Risk factors for

More information

How to Optimize Induction and Maintenance Responses: Definitions and Dosing Advances in Inflammatory Bowel Disease December 6, 2009

How to Optimize Induction and Maintenance Responses: Definitions and Dosing Advances in Inflammatory Bowel Disease December 6, 2009 How to Optimize Induction and Maintenance Responses: Definitions and Dosing 2009 Advances in Inflammatory Bowel Disease December 6, 2009 Fernando Velayos MD MPH University of California, San Francisco

More information

PROBIOTICS. what they are and what they can do for you. A patient s guide from your doctor and

PROBIOTICS. what they are and what they can do for you. A patient s guide from your doctor and PROBIOTICS what they are and what they can do for you A patient s guide from your doctor and Probiotics Products containing probiotics have flooded the market in recent years. As more people seek natural

More information

Dr. Elmer Schabel, MD. Bundesinstitut für Arzneimittel und Medizinprodukte, Bonn, Germany (No conflicts of interest)

Dr. Elmer Schabel, MD. Bundesinstitut für Arzneimittel und Medizinprodukte, Bonn, Germany (No conflicts of interest) EMA workshop on the development of new medicinal products for the treatment of ulcerative colitis and Crohn s disease Overview of authorised medicines for IBD in Europe - previous regulatory positions

More information

ULCERATIVE COLITIS FUNDING RESEARCH INTO DISEASES OF THE GUT, LIVER & PANCREAS

ULCERATIVE COLITIS FUNDING RESEARCH INTO DISEASES OF THE GUT, LIVER & PANCREAS ALL YOU NEED TO KNOW ABOUT ULCERATIVE COLITIS FUNDING RESEARCH INTO DISEASES OF THE GUT, LIVER & PANCREAS THIS FACTSHEET IS ABOUT ULCERATIVE COLITIS. Ulcerative colitis (UC) is a disease of the rectum

More information

ULCERATIVE COLITIS FUNDING RESEARCH INTO DISEASES OF THE GUT, LIVER & PANCREAS

ULCERATIVE COLITIS FUNDING RESEARCH INTO DISEASES OF THE GUT, LIVER & PANCREAS ALL YOU NEED TO KNOW ABOUT ULCERATIVE COLITIS FUNDING RESEARCH INTO DISEASES OF THE GUT, LIVER & PANCREAS THIS FACTSHEET IS ABOUT ULCERATIVE COLITIS. Ulcerative colitis (UC) is a disease of the rectum

More information

INFLAMMATORY BOWEL DISEASE 101: Understanding Your Child s Diagnosis

INFLAMMATORY BOWEL DISEASE 101: Understanding Your Child s Diagnosis INFLAMMATORY BOWEL DISEASE 101: Understanding Your Child s Diagnosis Phillip Minar, MD Pediatric Gastroenterologist Cincinnati Children s Hospital Medical Center Objectives What is IBD Crohn s disease

More information

-2002: Rectal blood loss, UC? (no definite diagnosis) rectal mesalazine. -June 2008: Recurrence of rectal blood loss and urgency

-2002: Rectal blood loss, UC? (no definite diagnosis) rectal mesalazine. -June 2008: Recurrence of rectal blood loss and urgency SD, male 40 yrs. old. (680718M467.) -2002: Rectal blood loss, UC? (no definite diagnosis) rectal mesalazine -June 2008: Recurrence of rectal blood loss and urgency Total colonoscopy: ulcerative rectitis,

More information

Evaluation of treatment effect in UC and CD (children)

Evaluation of treatment effect in UC and CD (children) Evaluation of treatment effect in UC and CD (children) Dr Nick Croft Digestive Diseases, Centre for Immunobiology, Blizard Institute & Barts Health NHS Trust Blizard Institute Disclosures Dr Nick Croft

More information

Probiotics in the ICU. Who could benefit? Nadia J van Rensburg RD(SA) Groote Schuur Hospital, Cape Town

Probiotics in the ICU. Who could benefit? Nadia J van Rensburg RD(SA) Groote Schuur Hospital, Cape Town Probiotics in the ICU. Who could benefit? Nadia J van Rensburg RD(SA) Groote Schuur Hospital, Cape Town Outline Introduction: a brief overview Probiotics: Current guidelines Reviews and Meta-analyses IBD

More information

CROHN S DISEASE AND ULCERATIVE COLITIS

CROHN S DISEASE AND ULCERATIVE COLITIS Slide 1 CROHN S DISEASE AND ULCERATIVE COLITIS Slide 2 Slide 3 Crohn s Inflammation in the GI tract but usually in the lower part of the small intestines and the colon. Inflammation occur between healthy

More information

Diagnostic and Therapeutic Approaches to Dysplasia in Inflammatory Bowel Diseases

Diagnostic and Therapeutic Approaches to Dysplasia in Inflammatory Bowel Diseases Diagnostic and Therapeutic Approaches to Dysplasia in Inflammatory Bowel Diseases Parakkal Deepak, M.B.B.S., M.S. Assistant Professor of Medicine Division of Gastroenterology John T. Milliken Department

More information

Medical therapies and IBD

Medical therapies and IBD Medical therapies and IBD Although there is no cure for IBD, there are many treatment options available. There is no standard treatment for IBD that is effective in all situations or for all patients,

More information

A Case of Inflammatory Bowel Disease

A Case of Inflammatory Bowel Disease A Case of Inflammatory Bowel Disease Dr Barrie Rathbone www.le.ac.uk 26 year old Polish woman Admitted as emergency under surgeons RUQ and RIF pain Abdominal pain had occurred intermittently for a few

More information

Algorithm for managing severe ulcerative colitis

Algorithm for managing severe ulcerative colitis Tropical Gastroenterology 2014;Suppl:S40 44 Algorithm for managing severe ulcerative colitis Vineet Ahuja 1, Ajay Kumar 2, Rakesh Kochhar 3 ABSTRACT Dept of Gastroenterology, 1 All India Institute of Medical

More information

NEW CONCEPTS IN CROHN S DISEASE GLENDON BURRESS, MD PEDIATRIC GASTROENTEROLOGY ROCKFORD, IL

NEW CONCEPTS IN CROHN S DISEASE GLENDON BURRESS, MD PEDIATRIC GASTROENTEROLOGY ROCKFORD, IL NEW CONCEPTS IN CROHN S DISEASE GLENDON BURRESS, MD PEDIATRIC GASTROENTEROLOGY ROCKFORD, IL CROHN S DISEASE Chronic disease of uncertain etiology Etiology- genetic, environmental, and infectious Transmural

More information

Pregnancy in IBD CDDW 2014

Pregnancy in IBD CDDW 2014 Pregnancy in IBD CDDW 2014 Brian Bressler MD, MS, FRCPC Director, Advanced IBD Training Program Clinical Assistant Professor of Medicine Division of Gastroenterology University of British Columbia Bressler

More information

What is ulcerative colitis?

What is ulcerative colitis? What is ulcerative colitis? Ulcerative colitis is a disease that causes inflammation and sores, called ulcers, in the lining of the rectum and colon. Ulcers form where inflammation has killed the cells

More information

INFLAMMATORY BOWEL DISEASE 101: From Hurdling New Diagnosis to Optimizing Treatments

INFLAMMATORY BOWEL DISEASE 101: From Hurdling New Diagnosis to Optimizing Treatments INFLAMMATORY BOWEL DISEASE 101: From Hurdling New Diagnosis to Optimizing Treatments Phillip Minar, MD Pediatric Gastroenterologist Cincinnati Children s Hospital Medical Center Objectives of Session What

More information

What s new in IBD? Dr AB Hawthorne Consultant Gastroenterologist University Hospital of Wales Cardiff

What s new in IBD? Dr AB Hawthorne Consultant Gastroenterologist University Hospital of Wales Cardiff What s new in IBD? Dr AB Hawthorne Consultant Gastroenterologist University Hospital of Wales Cardiff Case: Kelly age 19 Admitted via medical intake to local hospital with D&V for 10 days. Ate take-away

More information

WHAT IS ULCERATIVE COLITIS?

WHAT IS ULCERATIVE COLITIS? 235 60th Street, West New York, NJ 07093 T: (201) 854-4646 F: (201) 854-4647 810 Main Street, Hackensack, NJ 07601 T: (201) 488-0095 Ulcerative Colitis WHAT IS ULCERATIVE COLITIS? Ulcerative colitis is

More information

Inflammatory bowel disease. Kawa Obeid, PhD

Inflammatory bowel disease. Kawa Obeid, PhD Inflammatory bowel disease Kawa Obeid, PhD 63 Introduction Inflammatory bowel disease (IBD) can be divided into two chronic inflammatory disorders of the gastro- intestinal tract, namely Crohn's disease

More information

Ali Keshavarzian MD Rush University Medical Center

Ali Keshavarzian MD Rush University Medical Center Treatment: Step Up or Top Down? Ali Keshavarzian MD Rush University Medical Center Questions What medication should IBD be treated with? Can we predict which patients with IBD are high risk? Is starting

More information

What Are Probiotics? PROBIOTICS

What Are Probiotics? PROBIOTICS PROBIOTICS What Are Probiotics? Probiotics are living, microscopic (very small) organisms that can help your gut health. Most often, probiotics are bacteria, but they may also be other organisms, such

More information

CRC and Dysplasia in IBD: Objectives of Talk. Colorectal Cancer and Dysplasia in IBD: A Case-Based Approach. Page 1

CRC and Dysplasia in IBD: Objectives of Talk. Colorectal Cancer and Dysplasia in IBD: A Case-Based Approach. Page 1 Colorectal Cancer and in IBD: A Case-Based Approach Fernando Velayos MD MPH Associate Director of Translational Research University of California, San Francisco Center for Crohn s s and Colitis CRC and

More information

Title: Fecal microbiota transplantation in recurrent Clostridium difficile infection in a patient with concomitant inflammatory bowel disease

Title: Fecal microbiota transplantation in recurrent Clostridium difficile infection in a patient with concomitant inflammatory bowel disease Title: Fecal microbiota transplantation in recurrent Clostridium difficile infection in a patient with concomitant inflammatory bowel disease Authors: Marta Gravito-Soares, Elisa Gravito-Soares, Francisco

More information

Medical Management of Inflammatory Bowel Disease

Medical Management of Inflammatory Bowel Disease Medical Management of Inflammatory Bowel Disease John K. Marshall MD MSc FRCPC AGAF Division of Gastroenterology McMaster University John K. Marshall: Conflicts of Interest Speaker: AbbVie, Allergan, Ferring,

More information

The Role of Surgery in Inflammatory Bowel Disease. Cory D Barrat, MD Colon and Rectal Surgeon Mercy Health

The Role of Surgery in Inflammatory Bowel Disease. Cory D Barrat, MD Colon and Rectal Surgeon Mercy Health The Role of Surgery in Inflammatory Bowel Disease Cory D Barrat, MD Colon and Rectal Surgeon Mercy Health THANKS FOR INVITING ME! I have no financial disclosures Outline - Who am I and what do I do? -

More information

Treating inflammatory bowel disease

Treating inflammatory bowel disease Treating inflammatory bowel disease Topical mesalazine (Enema and Suppository) Information for patients Gastroenterology page 2 of 8 What is my medicine? Mesalazine enemas and suppositories are used in

More information

Clinically proven to quickly relieve symptoms of common gastrointestinal disorders. TERRAGASTRO - Good health starts in the gut

Clinically proven to quickly relieve symptoms of common gastrointestinal disorders. TERRAGASTRO - Good health starts in the gut Clinically proven to quickly relieve symptoms of common gastrointestinal disorders GASTROINTESTINAL DISEASE Referred to as gastrointestinal diseases, they are common disorders which affect the esophagus,

More information

Formulations and Availability 900 BILLION 5,319 HIGH POTENCY PROBIOTIC PEDIATRIC ADULT GERIATRIC PROVEN BY RESEARCH. HIGH-POTENCY. NO SHORTCUTS.

Formulations and Availability 900 BILLION 5,319 HIGH POTENCY PROBIOTIC PEDIATRIC ADULT GERIATRIC PROVEN BY RESEARCH. HIGH-POTENCY. NO SHORTCUTS. Formulations and Availability S TU D I E S PE R D I S E A S E 39 LIVER Liver Disease, Cirrhosis, Liver Failure, Hepatic Encephalopathy S TU D I E S PE R AG E G RO U P Visbiome Regular Product Code: 693-0412-01

More information

Patho Basic Chronic Inflammatory Bowel Diseases. Jürg Vosbeck Pathology

Patho Basic Chronic Inflammatory Bowel Diseases. Jürg Vosbeck Pathology Patho Basic Chronic Inflammatory Bowel Diseases Jürg Vosbeck Pathology General Group of chronic relapsing diseases with chronic bloody or watery diarrhea Usually ulcerative colitis (UC) or Crohn s disease

More information

There is no single IBD diet

There is no single IBD diet Nutrition and IBD There is no single IBD diet Nutrition plays an important role in health, during times of IBD disease activity as well as during remission. Although diet does not cause or cure IBD, the

More information

Crohn's disease CAUSES COURSE OF CROHN'S DISEASE TREATMENT. Sulfasalazine

Crohn's disease CAUSES COURSE OF CROHN'S DISEASE TREATMENT. Sulfasalazine Crohn's disease Crohn's disease is an inflammatory condition of the digestive tract that affects children and adults. Common features of Crohn's disease include mouth sores, diarrhea, abdominal pain, weight

More information

Constipation Information Leaflet THE DIGESTIVE SYSTEM. gutscharity.org.uk

Constipation Information Leaflet THE DIGESTIVE SYSTEM.   gutscharity.org.uk THE DIGESTIVE SYSTEM http://healthfavo.com/digestive-system-for-kids.html This factsheet is about Constipation Constipation is a symptom that can mean different things to different people but the usual

More information

Proctitis Workshop. PD Dr Michel H. Maillard, MD-PhD 1,2. Crohn s and Colitis Center, Gastroentérologie Beaulieu SA.

Proctitis Workshop. PD Dr Michel H. Maillard, MD-PhD 1,2. Crohn s and Colitis Center, Gastroentérologie Beaulieu SA. Proctitis Workshop PD Dr Michel H. Maillard, MD-PhD 1,2 1 Crohn s and Colitis Center, Gastroentérologie Beaulieu SA 2 CHUV, Lausanne PD Dr Lukas Brügger, Universitätsklinik für Viszerale Chirurgie und

More information

INFLAMMATORY BOWEL DISEASE

INFLAMMATORY BOWEL DISEASE 1. Medical Condition INFLAMMATORY BOWEL DISEASE (IBD) specifically includes Crohn s disease (CD) and ulcerative colitis (UC) but also includes IBD unclassified (IBDu), seen in about 10% of cases. These

More information

Biologics in IBD. Brian P. Bosworth, MD, NYSGEF Associate Professor of Medicine Weill Cornell Medical College

Biologics in IBD. Brian P. Bosworth, MD, NYSGEF Associate Professor of Medicine Weill Cornell Medical College Biologics in IBD Brian P. Bosworth, MD, NYSGEF Associate Professor of Medicine Weill Cornell Medical College Case 30 year old man diagnosed with ulcerative proctitis diagnosed in 2003 Had been maintained

More information

Gut Microbiota and IBD. Vahedi. H M.D Associate Professor of Medicine DDRI

Gut Microbiota and IBD. Vahedi. H M.D Associate Professor of Medicine DDRI Gut Microbiota and IBD Vahedi. H M.D Associate Professor of Medicine DDRI 1393.3.1 2 GUT MICROBIOTA 100 Trillion Microbes - 10 times more than cells in our body Collective weight of about 1kg in human

More information

Mucosal healing: does it really matter?

Mucosal healing: does it really matter? Oxford Inflammatory Bowel Disease MasterClass Mucosal healing: does it really matter? Professor Jean-Frédéric Colombel, New York, USA Oxford Inflammatory Bowel Disease MasterClass Mucosal healing: does

More information

5/2/2018 SHOULD DEEP REMISSION BE A TREATMENT GOAL? YES! Disclosures: R. Balfour Sartor, MD

5/2/2018 SHOULD DEEP REMISSION BE A TREATMENT GOAL? YES! Disclosures: R. Balfour Sartor, MD 5/2/218 SHOULD DEEP REMISSION BE A TREATMENT GOAL? YES! Disclosures: R. Balfour Sartor, MD Grant support for preclinical studies: Janssen, Gusto Global, Vedanta, Artizan BALFOUR SARTOR, MD DISTINGUISHED

More information

Speaker Introduction

Speaker Introduction Speaker Introduction Stephen B. Hanauer, MD Professor of Medicine and Clinical Pharmacology University of Chicago Pritzker School of Medicine Chief of Gastroenterology, Hepatology, and Nutrition University

More information

Anne Griffiths MD, FRCPC. SickKids Hospital, University of Toronto. Buenos Aires, August 16, 2014

Anne Griffiths MD, FRCPC. SickKids Hospital, University of Toronto. Buenos Aires, August 16, 2014 Management and Medical Therapies for Crohn disease: strategies to enhance mucosal healing Anne Griffiths MD, FRCPC SickKids Hospital, University of Toronto Buenos Aires, August 16, 2014 New onset Crohn

More information

Ulcerative Colitis Therapy. Faculty Disclosure. Acknowledgements 28/11/2013. Amy Morse November 30/13

Ulcerative Colitis Therapy. Faculty Disclosure. Acknowledgements 28/11/2013. Amy Morse November 30/13 Ulcerative Colitis Therapy Amy Morse November 30/13 GI for GP s Jasper AB Faculty Disclosure Faculty: Amy Morse Relationships with commercial interests: Grants/Research Support: Therapeutic Fellowship

More information

I B D. etter than this. isease UNDERSTANDING INFLAMMATORY BOWEL DISEASES

I B D. etter than this. isease UNDERSTANDING INFLAMMATORY BOWEL DISEASES I B D m etter than this isease UNDERSTANDING INFLAMMATORY BOWEL DISEASES What types of people have learned how to manage their IBD? Athletes Musicians Firefighters DOCTORS HEROES Artists Presidents Actors

More information

DENOMINATOR: All patients aged 18 and older with a diagnosis of inflammatory bowel disease

DENOMINATOR: All patients aged 18 and older with a diagnosis of inflammatory bowel disease Measure #270: Inflammatory Bowel Disease (IBD): Preventive Care: Corticosteroid Sparing Therapy National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY

More information

Improving outcome of Inflammatory Bowel Disease in children

Improving outcome of Inflammatory Bowel Disease in children Improving outcome of Inflammatory Bowel Disease in children Dinesh Pashankar, MD Pediatric Gastroenterologist Director- Pediatric IBD program Yale University School of Medicine Pediatric Gastroenterology

More information

Aminosalicylates in Inflammatory Bowel Disease in Adults (Review date: July 2020) Page 1

Aminosalicylates in Inflammatory Bowel Disease in Adults (Review date: July 2020) Page 1 Full Title of Guideline: Author (include email and role): Aminosalicylates in Inflammatory Bowel Disease in Adults Natalie Tse- Senior Clinical Pharmacist (natalie.tse@nuh.nhs.uk) Dr. Nina Lewis- Consultant

More information

The Spectrum of IBD. Inflammatory Bowel Disease. Symptoms. Epidemiology. Tests for IBD. CD or UC? Inflamatory Bowel Disease. Fernando Vega, M.D.

The Spectrum of IBD. Inflammatory Bowel Disease. Symptoms. Epidemiology. Tests for IBD. CD or UC? Inflamatory Bowel Disease. Fernando Vega, M.D. The Spectrum of IBD Inflammatory Bowel Disease Fernando Vega, M.D. Epidemiology CD and UC together 1:400 UC Prevalence 1:500 UC Incidence 6-12K/annum CD Prevalence 1:1000 CD Incidence 3-6K/annum Symptoms

More information

COLON HYDROTHERAPY CONSENT FORM

COLON HYDROTHERAPY CONSENT FORM Last Name: First Name: FOR OFFICE USE COLON HYDROTHERAPY CONSENT FORM Client No: Origination date: Note: Client Name: Date: / / Preferred Phone: Text: Y / N Email: Email: Y / N Address: State: Zip Code:

More information

An Update on the Biologic Treatment for Patients with Inflammatory Bowel Disease. David A. Schwartz, MD

An Update on the Biologic Treatment for Patients with Inflammatory Bowel Disease. David A. Schwartz, MD An Update on the Biologic Treatment for Patients with Inflammatory Bowel Disease David A. Schwartz, MD Director, Inflammatory Bowel Disease Center Associate Professor of Medicine Vanderbilt University

More information

Hot Topics In Nutrition & IBD January 6, Kate Vance, RD Wael N. Sayej, MD

Hot Topics In Nutrition & IBD January 6, Kate Vance, RD Wael N. Sayej, MD Hot Topics In Nutrition & IBD January 6, 2018 Kate Vance, RD Wael N. Sayej, MD Nutrients of Focus Calories Calcium Vitamin D Iron Nutritional Treatment in IBD Improve nutritional status As primary therapy

More information

Treating Crohn s and Colitis in the ASC

Treating Crohn s and Colitis in the ASC Treating Crohn s and Colitis in the ASC Kimberly M Persley, MD Texas Digestive Disease consultants TASC Meeting Outline IBD 101 Diagnosis Treatment Burden of Disease Role of ASC Inflammatory Bowel Disease

More information

Azienda Ospedaliera S. Camillo Forlanini. Unità Operativa di Gastroenterologia. Moscow June Cosimo Prantera

Azienda Ospedaliera S. Camillo Forlanini. Unità Operativa di Gastroenterologia. Moscow June Cosimo Prantera / Azienda Ospedaliera S. Camillo Forlanini Unità Operativa di Gastroenterologia Moscow June 2006 Cosimo Prantera ANTIBIOTICS AND BACTERIAL SPECIES Metronidazole Bacteroides - Clostridia Ciprofloxacin Escherichia

More information

Clinical Trials in IBD. Bruce Yacyshyn MD Professor of Medicine Division of Digestive Diseases

Clinical Trials in IBD. Bruce Yacyshyn MD Professor of Medicine Division of Digestive Diseases Clinical Trials in IBD Bruce Yacyshyn MD Professor of Medicine Division of Digestive Diseases Objectives Today s discussion will address the following topics: Similarities and differences between Crohn

More information

Clinical Study Clinical Study of the Relation between Mucosal Healing and Long-Term Outcomes in Ulcerative Colitis

Clinical Study Clinical Study of the Relation between Mucosal Healing and Long-Term Outcomes in Ulcerative Colitis Hindawi Publishing Corporation Gastroenterology Research and Practice Volume 2013, Article ID 192794, 6 pages http://dx.doi.org/10.1155/2013/192794 Clinical Study Clinical Study of the Relation between

More information

Understanding probiotics and health

Understanding probiotics and health Understanding probiotics and health Gemma Laws MSc Student Microbiology and Immunology Department The gut microbiota The name given to the total microbial population living in our intestine Bacteria, fungi,

More information

FERRING PHARMACEUTICALS. Enjoy The simple COR/939/2014/CH3

FERRING PHARMACEUTICALS. Enjoy The simple COR/939/2014/CH3 Enjoy The simple pleasures of life COR/939/2014/CH3 Ulcerative colitis disrupts the simple pleasures in life Patients with ulcerative colitis may live with a considerable symptom burden despite medical

More information

Crohn's Disease. What causes Crohn s disease? What are the symptoms?

Crohn's Disease. What causes Crohn s disease? What are the symptoms? Crohn's Disease Crohn s disease is an ongoing disorder that causes inflammation of the digestive tract, also referred to as the gastrointestinal (GI) tract. Crohn s disease can affect any area of the GI

More information